强心保心方治疗冠心病慢性心力衰竭的临床疗效及对胱抑素C、β2微球蛋白指标的影响

摘要

目的:观察强心保心方对冠心病慢性心力衰竭的临床疗效及对胱抑素 C、β2微球蛋白指标的影响.方法:将60例冠心病慢性心力衰竭患者随机分为治疗组和对照组.对照组给予西医常规治疗,治疗组在对照组的基础上给予强心保心方,治疗前后评价两组患者的中医证候、心功能分级、血清胱抑素C及β2微球蛋白变化情况.结果:治疗组疗效优于对照组.结论:在西医常规治疗基础上加用强心保心方治疗冠心病慢性心力衰竭的疗效优于单纯西医常规治疗,并且能预防肾脏病变,起到未病先防,既病防变之效.%Objective:To observe the clinical curative effect of Qiang Xin Bao Xin direction in the treatment of coronary heart disease chronic heart failure and the influence on the cystatin C,beta 2 microglobulin index.Methods:60 patients with coronary heart disease chronic heart failure were randomly divided into the treatment group and the control group.The control group was given conventional western medicine treatment.The treatment group Qiang Xin Bao Xin direction on the basis of the control group. Before and after treatment,the TCM symptoms,heart function grading and serum cystatin C and beta 2 microglobulin changes of two groups were evaluated.Results:The curative effect of the treatment group was better than that of the control group.Conclusion:On the basis of conventional western medicine treatment,Qiang Xin Bao Xin direction in the treatment of patients with coronary heart disease chronic heart failure is better than western medicine routine treatment,and can prevention renal lesions,has the effect of prevention before disease onset and preventing disease from exacerbating.